NEUPERT PETER M 4
4 · Adaptive Biotechnologies Corp · Filed Mar 12, 2025
Insider Transaction Report
Form 4
NEUPERT PETER M
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-10$4.07/sh+50,000$203,500→ 234,690 total - Exercise/Conversion
Stock Option (right to buy)
2025-03-10−50,000→ 0 totalExercise: $4.07Exp: 2025-03-31→ Common Stock (50,000 underlying) - Sale
Common Stock
2025-03-10$7.05/sh−10,000$70,500→ 224,690 total
Footnotes (2)
- [F1]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.03 to 7.07, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- [F2]The option was fully vested and exercisable.